DOCSLIB.ORG

Immpact Report

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Immpact Report MCGOVERN MEDICAL SCHOOL’S BROWN FOUNDATION INSTITUTE of MOLECULAR MEDICINE FOR THE PREVENTION of HUMAN DISEASES IMMpact Report FISCAL YEAR 2017 About the cover It’s a beautiful day at McGovern Medical School’s Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases. IMMpact Report is published by McGovern Medical School. All correspondence should be addressed to: Office of Communications 6431 Fannin, B.340 Houston, TX 77030 E-mail: [email protected] Articles and photos may be reprinted with permission. Editor Darla Brown, Director, Office of Communications Contributors: Darla Brown Rob Cahill Jonathan Garris IMM Faculty Design: Roy Prichard Photography: Dwight Andrews Maricruz Kwon For information on supporting programs at the McGovern Medical School and the IMM, contact Lise Cameron, 713.500.3602, [email protected] OOC-ThomasPrintworks-1175-3/18 Contents 2 Director's Message Features 3 Mission 4 Our Locations 6 8 16 Center for Cardiovascular Genetics Gene editing – Moving promising it starts therapeutics into 20 Center for Human Genetics in the lab practice 25 Center for Immunology and Autoimmune Diseases 31 Center for Metabolic and Degenerative Diseases 40 Center for Molecular Imaging 11 12 Breathing new life Entering uncharted 48 Center for Precision Biomedicine into lung disease genome territory research in the fight 57 Center for Stem Cell and Regenerative Medicine against disease 74 Center for Tissue Engineering and Aging Research 81 Texas Therapeutics Institute 14 IMM 90 IMM Service Centers Cheering on the IMM PACT REPORT 92 By the Numbers 93 Gift Report • • • • 1 Director’s Message ’m pleased to introduce the latest annual IMMpact report for The Brown Foundation Institute of Molecular Medicine for the Prevention Iof Human Diseases (IMM). The IMM is a stand-alone research institute that is embedded within McGovern Medical School. The IMM mission is to deliver translational outcomes from research in molecular medicine that benefits patients. To this end, we have teams of outstanding basic and translational scientists who collaborate closely with our clinical colleagues. Inside the report you will find in-depth articles on some of our faculty and donors plus an account from each IMM faculty member describing their research programs. This year we have recruited additional outstanding new faculty, who bring with them exciting research ideas and innovative technologies. Two of our new recruits, whose stories are featured, also secured prestigious STARs awards from The University of Texas System, which are reserved for the recruitment of highly sought-after scientists. The environment for scientific research funding continues to be extremely challenging, especially The IMM has from the NIH. Despite this, IMM faculty have excelled again. Over the two major financial year just ended, our new grants and contracts were up some 30 percent over the preceding year, which in turn had seen a considerable objectives: increase over the prior year. It is a testament to the remarkable quality and Mission creativity of our scientists that the IMM remains so successful in attracting research funds from what is an ever-diminishing national pool. That Discovery is the 1 said, full implementation of our mission remains heavily dependent on he Brown Foundation research and the future practice to medical practice are of highest priority for attracting support from alternative sources, including research foundations, Institute of Molecular of medicine with more novel major importance to product the IMM faculty. This industry collaborations, and, most importantly, the continuing generosity Medicine for the therapies. These approaches development in biotechnology is a major challenge, of our friends and donors. T Prevention of Human Diseases since diabetes, obesity, In addition to advancing science and medicine, we wish to develop have been most successfully and the pharmaceutical cancer, Alzheimer’s, and our relationships with all in our community who value the aspiration (IMM) is a research institute used to determine the causes of industry, the IMM has cardiovascular diseases of our mission to translate molecular discoveries into new therapies for that seeks to investigate the infectious disorders and genetic the potential and desire to are unsolved medical human disease. In this regard, we are deeply appreciative of the strong causes of human diseases at diseases. form important links and work and dedication of the IMM advisory council, which plays a key role problems that are not the cellular and molecular However, it is clear that collaborations between its caused by single gene in the continued growth and development of the IMM. If you would levels, using DNA and protein molecular and cell biology own research activities and defects. Discoveries lead like to investigate how you can also be involved, I would be delighted to talk with you personally. Alternatively, I would be delighted to see you at technologies to elucidate disease will play a major role in various industries to apply its to new solutions. our annual IMMpact symposium. Last year 165 guests listened to three mechanisms. This development clarifying the causes of many discoveries and intellectual talks in the Beth Robertson Auditorium and attended a reception in New diagnostics and and progress are of particular unsolved problems of modern properties to pharmaceutical 2 the James T. Willerson, M.D. Discovery Hall. This year the symposium therapies are derivative will be held on April 18, 2018, and will feature talks on how to use new interest for future planning medicine, such as heart opportunities. of discovery and to the gene editing technologies to correct inherited diseases. The format will in the increasingly important disease, hypertension, vascular As an institute of McGovern benefit of patients. The be slightly different from previous years in that we will have an extended area of clinical research. The disorders, major mental Medical School, the Brown IMM focuses on these question time with an expert panel comprising the speakers plus UTHealth institute endeavors to design illnesses, and inflammatory Foundation Institute of medical solutions. The physicians. The symposium is an excellent opportunity to hear exciting methods of rational therapy and immunologic diseases. Molecular Medicine for the IMM has organized research stories directly from our faculty, to discuss its implications for talent in the Texas the future of medicine and health care, and to have all your questions and, wherever possible, The research of the institute’s Prevention of Human Diseases Therapeutics Institute answered. Full details are in this report; please mark the date in your strategies for the prevention of investigators is inspiring and strives to set the example IMM specifically to achieve calendar because it is a great opportunity to visit the IMM. human diseases. promises to fulfill the mission for research excellence and PACT REPORT this goal of patient Advances in molecular and of the IMM. collaboration locally, nationally, John Hancock, M.A., M.B., B.Chir., Ph.D., Sc.D. benefit from discovery. PACT REPORT Executive Director, Institute of Molecular Medicine cell biology have enormous Because the applications and internationally. IMM John S. Dunn Distinguished University Chair in Physiology and Medicine potential for innovative medical of molecular and cell biology • • • • • • • • 2 3 Our Locations e Brown Foundation Fayez S. Sarofim Research Building Institute of • Primary home of the IMM’s faculty, Molecular Medicine for the administration, and support staff. Prevention of Human Diseases • Located adjacent to the The University of Texas Health Science Center at Houston (UTHealth) University Center Tower within IMMpact the Texas Medical Center. • Opened in 2006, the building encompasses 255,748 gross square feet. Symposium South Campus Research Building – 3 (SCRB3) • SCRB3 is a collaboration between The University of Texas MD Anderson Cancer Wednesday Center and UTHealth, in cooperation with GE Healthcare and the Texas Enterprise Fund. April 18, 2018 • Six-stories, 315,000 square-feet located on the South Campus of the Texas Medical Center. 4:00-6:30 p.m. • Opened in 2009, this facility houses Positron Emission Tomography, Magnetic Resonance Imaging, Optical Imaging Tracers, a Fayez S. Sarofim Research Building Cyclotron, wet labs, and support offices. 1825 Pressler Street The Denton A. Cooley Building – Texas Heart Institute at St. Luke’s Episcopal Hospital Editing the Cut, Copy, Paste: Muscular • The IMM occupies a 31,000 square-foot high- Gene correction in Dystrophies: new tech laboratory. human Cystic Fibrosis hope from gene • Located in the Texas Medical Center. genome: the editing Brian Davis, PhD future is now Director of the Center for Stem Cell and Radbod Darabi, MD, PhD Regenerative Medicine Assistant Professor, Center for Stem Cell C. Harold and Lorine G. Wallace and Regenerative Medicine IMM Distinguished University Chair PACT REPORT PACT REPORT IMM • • • • • • • • 4 SAVE THE DATE 5 Profiles in research Gene editing – it starts in the lab ll green thumbs know that affects more than 30,000 specific cells (e.g. lung cells) that pruning is key to a people in the United States. The to that patient,” he explains. Ahealthy garden. Just as blood cells are from immune “This eliminates the need to use all good writers know that edit- deficiency patients who suffer donor stem cells from another ing keeps copy sharp. from recurrent infections. individual, minimizing the body Brian Davis, Ph.D., director “Our goal for the lung is to rejecting the cell.” of the IMM’s Center for Stem isolate, expand, and edit the In addition to creating stem Cell & Regenerative Medicine, stem cells as they exist in the cells, the tools used to specifi- uses these concepts of pruning airway and deliver them back cally correct gene defects are be- and editing in the laboratory healthy to the patient,” Dr. Da- coming more useful and precise. to modify genes – weeding out vis says. “The lung might not be “We can highlight an area to the errors in hopes of making the easiest place to reintroduce a cut and paste to make a specific patients healthy again.
Load more

Recommended publications
  • The Ligand-Specific Co-Receptor Function of CD44 for Receptor
    The ligand-specific co-receptor function of CD44 for receptor tyrosine kinases Zur Erlangung des akademischen Grades eines DOKTORS DER NATURWISSENSCHAFTEN (Dr. rer. nat.) Fakultät für Chemie und Biowissenschaften Karlsruher Institut für Technologie (KIT) - Universitätsbereich genehmigte DISSERTATION von Christian Jung aus Karlsruhe Dekan: Prof. Dr. Martin Bastmeyer Referent: PD Dr. Véronique Orian-Rousseau Korreferent: Prof. Dr. Doris Wedlich Tag der mündlichen Prüfung: 18.4.2012 I Ich versichere, dass ich meine Arbeit selbständig angefertigt und keine anderen als die angegebenen Quellen und Hilfsmittel benutzt, sowie die wörtlich oder inhaltlich übernommenen Stellen als solche kenntlich gemacht und die Satzung der Universität Karlsruhe (TH) zur Sicherung guter wissenschaftlicher Praxis in der jeweils gültigen Fassung beachtet habe. Christian Jung, März 2012 II Zusammenfassung Listeria monocytogenes, ein gram-positives Bakterium, verursacht die Krankheit Listeriose. Eine Möglichkeit, wie L.monocytogenes Wirbeltierzellen infizieren kann, ist das Binden des Bakteriums an die Rezeportyrosinkinase (RTK) Met auf der Wirtszelle durch das bakterielle Protein InlB. Dieses Binden führt zur Aktivierung von Met und schließlich zur Aufnahme in die Zelle. Der erste Teil meine Doktorarbeit zeigt, dass die Infektion von nicht-phagozytotischen Zellen mittels InlB zusätzlich vom Ko-Rezeptor CD44v6 abhängig ist. Desweiteren kann diese bakterielle Infektion mit einem CD44v6-Peptid blockiert werden. Zusätzlich zu der Ko-Rezeptorfunktion von CD44v6 für InlB und Met, die ich gezeigt habe, wurde CD44v6 bereits als Ko-Rezeptor für die Induktion von Met und VEGFR- 2 durch ihre authentischen Liganden HGF and VEGF-A identifiziert. Im zweiten und Hauptteil meiner Doktorarbeit habe ich untersucht, ob diese Ko-Rezeptorfunktion von CD44v6 spezifisch von den Liganden, den Rezeptoren oder beiden bestimmt wird.
    [Show full text]
  • In Vivo Dual RNA-Seq Analysis Reveals the Basis for Differential Tissue Tropism of Clinical Isolates of Streptococcus Pneumoniae
    In Vivo Dual RNA-Seq Analysis Reveals the Basis for Differential Tissue Tropism of Clinical Isolates of Streptococcus pneumoniae Vikrant Minhas,1,4 Rieza Aprianto,2,4 Lauren J. McAllister,1 Hui Wang,1 Shannon C. David,1 Kimberley T. McLean,1 Iain Comerford,3 Shaun R. McColl,3 James C. Paton,1,5,6,* Jan-Willem Veening,2,5 and Claudia Trappetti,1,5 Supplementary Information Supplementary Table 1. Pneumococcal differential gene expression in the lungs 6 h post-infection, 9-47-Ear vs 9-47M. Genes with fold change (FC) greater than 2 and p < 0.05 are shown. FC values highlighted in blue = upregulated in 9-47-Ear, while values highlighted in red = upregulated in 9- 47M. Locus tag in 9-47- Product padj FC Ear Sp947_chr_00844 Sialidase B 3.08E-10 313.9807 Sp947_chr_02077 hypothetical protein 4.46E-10 306.9412 Sp947_chr_00842 Sodium/glucose cotransporter 2.22E-09 243.4822 Sp947_chr_00841 N-acetylneuraminate lyase 4.53E-09 227.7963 scyllo-inositol 2-dehydrogenase Sp947_chr_00845 (NAD(+)) 4.36E-09 221.051 Sp947_chr_00848 hypothetical protein 1.19E-08 202.7867 V-type sodium ATPase catalytic subunit Sp947_chr_00853 A 1.29E-06 100.5411 Sp947_chr_00846 Beta-glucoside kinase 3.42E-06 98.18951 Sp947_chr_00855 V-type sodium ATPase subunit D 8.34E-06 85.94879 Sp947_chr_00851 V-type sodium ATPase subunit C 2.50E-05 72.46612 Sp947_chr_00843 hypothetical protein 2.17E-05 65.97758 Sp947_chr_00839 HTH-type transcriptional regulator RpiR 3.09E-05 61.28171 Sp947_chr_00854 V-type sodium ATPase subunit B 1.32E-06 50.86992 Sp947_chr_00120 hypothetical protein 3.00E-04
    [Show full text]
  • Investigation of Peptidyl-Prolyl Cis/Trans Isomerases in the Virulence of Staphylococcus
    Investigation of Peptidyl-prolyl cis/trans isomerases in the virulence of Staphylococcus aureus A Dissertation presented to the faculty of the College of Arts and Sciences of Ohio University In partial fulfillment of the requirements for the degree Doctor of Philosophy Rebecca A. Keogh August 2020 © 2020 Rebecca A. Keogh. All Rights Reserved. 2 This Dissertation titled Investigation of Peptidyl-prolyl cis/trans isomerases in the virulence of Staphylococcus aureus by REBECCA A. KEOGH has been approved for the Department of Biological Sciences and the College of Arts and Sciences by Ronan K. Carroll Assistant Professor of Biological Sciences Florenz Plassmann Dean, College of Arts and Sciences 3 ABSTRACT REBECCA A. KEOGH, Doctorate of Philosophy, August 2020, Biological Sciences Investigation of peptidyl-prolyl cis/trans isomerases in the virulence of Staphylococcus aureus Director of Dissertation: Ronan K. Carroll Staphylococcus aureus is a leading cause of both hospital and community- associated infections that can manifest in a wide range of diseases. These diseases range in severity from minor skin and soft tissue infections to life-threatening sepsis, endocarditis and meningitis. Of rising concern is the prevalence of antibiotic resistant S. aureus strains in the population, and the lack of new antibiotics being developed to treat them. A greater understanding of the ability of S. aureus to cause infection is crucial to better inform treatments and combat these antibiotic resistant superbugs. The ability of S. aureus to cause such diverse infections can be attributed to the arsenal of virulence factors produced by the bacterium that work to both evade the human immune system and assist in pathogenesis.
    [Show full text]
  • Novel Therapeutic Interventions Towards Improved Management of Septic Arthritis Jian Wang1* and Liucai Wang2
    Wang and Wang BMC Musculoskeletal Disorders (2021) 22:530 https://doi.org/10.1186/s12891-021-04383-6 REVIEW Open Access Novel therapeutic interventions towards improved management of septic arthritis Jian Wang1* and Liucai Wang2 Abstract Septic arthritis (SA) represents a medical emergency that needs immediate diagnosis and urgent treatment. Despite aggressive treatment and rapid diagnosis of the causative agent, the mortality and lifelong disability, associated with septic arthritis remain high as close to 11%. Moreover, with the rise in drug resistance, the rates of failure of conventional antibiotic therapy have also increased. Among the etiological agents frequently isolated from cases of septic arthritis, Staphylococcus aureus emerges as a dominating pathogen, and to worsen, the rise in methicillin- resistant S. aureus (MRSA) isolates in bone and joint infections is worrisome. MRSA associated cases of septic arthritis exhibit higher mortality, longer hospital stay, and higher treatment failure with poorer clinical outcomes as compared to cases caused by the sensitive strain i.e methicillin-sensitive S. aureus (MSSA). In addition to this, equal or even greater damage is imposed by the exacerbated immune response mounted by the patient’s body in a futile attempt to eradicate the bacteria. The antibiotic therapy may not be sufficient enough to control the progression of damage to the joint involved thus, adding to higher mortality and disability rates despite the prompt and timely start of treatment. This situation implies that efforts and focus towards studying/ understanding new strategies for improved management of sepsis arthritis is prudent and worth exploring. The review article aims to give a complete insight into the new therapeutic approaches studied by workers lately in this field.
    [Show full text]
  • 2011/109440 Al
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date _ . 9 September 2011 (09.09.2011) 2011/109440 Al (51) International Patent Classification: [CH/CH]; Chemin Des Chevreuils 1, 1188 Gimel (CH). C12Q 1/68 (2006.01) G01N 33/53 (2006.01) HOLTERMAN, Daniel [US/US]; 14465 North 14th St., Phoenix, AZ 85022 (US). (21) International Application Number: PCT/US201 1/026750 (74) Agent: AKHAVAN, Ramin; Caris Life Sciences, Inc., 6655 N. MacArthur Blvd., Irving, TX 75039 (US). (22) International Filing Date: 1 March 201 1 (01 .03.201 1) (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, English (25) Filing Language: AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, (26) Publication Language: English CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (30) Priority Data: HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, 61/274,124 1 March 2010 (01 .03.2010) US KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, 61/357,5 17 22 June 2010 (22.06.2010) US ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, 61/364,785 15 July 2010 (15.07.2010) us NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, (71) Applicant (for all designated States except US): CARIS SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, LIFE SCIENCES LUXEMBOURG HOLDINGS [LU/ TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
    [Show full text]
  • Signal Transduction, Quorum-Sensing, and Extracellular Protease Activity in Enterococcus Faecalis Biofilm Formation
    Signal Transduction, Quorum-Sensing, and Extracellular Protease Activity in Enterococcus faecalis Biofilm Formation The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Carniol, K., and M. S. Gilmore. 2004. Signal Transduction, Quorum- Sensing, and Extracellular Protease Activity in Enterococcus Faecalis Biofilm Formation. Journal of Bacteriology 186, no. 24: 8161–8163. doi:10.1128/jb.186.24.8161-8163.2004. Published Version doi:10.1128/JB.186.24.8161-8163.2004 Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:33867369 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA JOURNAL OF BACTERIOLOGY, Dec. 2004, p. 8161–8163 Vol. 186, No. 24 0021-9193/04/$08.00ϩ0 DOI: 10.1128/JB.186.24.8161–8163.2004 Copyright © 2004, American Society for Microbiology. All Rights Reserved. GUEST COMMENTARY Signal Transduction, Quorum-Sensing, and Extracellular Protease Activity in Enterococcus faecalis Biofilm Formation Karen Carniol1,2 and Michael S. Gilmore1,2* Department of Ophthalmology, Harvard Medical School,1 and The Schepens Eye Research Institute,2 Boston, Massachusetts Biofilms are surface-attached communities of bacteria, en- sponse regulator proteins (10). Only one of the mutants gen- cased in an extracellular matrix of secreted proteins, carbohy- erated, fsrA, impaired the ability of E. faecalis strain V583A to drates, and/or DNA, that assume phenotypes distinct from form biofilms in vitro.
    [Show full text]
  • Host and Bacterial Determinants of Staphylococcus Aureus Nasal Colonization in Humans
    University of Central Florida STARS Electronic Theses and Dissertations, 2004-2019 2014 Host and Bacterial Determinants of Staphylococcus aureus Nasal Colonization in Humans Gowrishankar Muthukrishnan University of Central Florida Part of the Medical Sciences Commons Find similar works at: https://stars.library.ucf.edu/etd University of Central Florida Libraries http://library.ucf.edu This Doctoral Dissertation (Open Access) is brought to you for free and open access by STARS. It has been accepted for inclusion in Electronic Theses and Dissertations, 2004-2019 by an authorized administrator of STARS. For more information, please contact [email protected]. STARS Citation Muthukrishnan, Gowrishankar, "Host and Bacterial Determinants of Staphylococcus aureus Nasal Colonization in Humans" (2014). Electronic Theses and Dissertations, 2004-2019. 1289. https://stars.library.ucf.edu/etd/1289 HOST AND BACTERIAL DETERMINANTS OF STAPHYLOCOCCUS AUREUS NASAL COLONIZATION IN HUMANS by GOWRISHANKAR MUTHUKRISHNAN M.E. Birla Institute of Technology and Science, Pilani, India, 2007 M.S. University of Central Florida, United States of America, 2010 A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Burnett School of Biomedical Sciences in the College of Medicine at the University of Central Florida Orlando, Florida Summer Term 2014 Major Professor: Alexander M. Cole © 2014 Gowrishankar Muthukrishnan ii ABSTRACT Staphylococcus aureus (SA), an opportunistic pathogen colonizing the anterior nares in approximately 30% of the human population, causes severe hospital-associated and community-acquired infections. SA nasal carriage plays a critical role in the pathogenesis of staphylococcal infections and SA eradication from the nares has proven to be effective in reducing endogenous infections.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2006/0110747 A1 Ramseier Et Al
    US 200601 10747A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2006/0110747 A1 Ramseier et al. (43) Pub. Date: May 25, 2006 (54) PROCESS FOR IMPROVED PROTEIN (60) Provisional application No. 60/591489, filed on Jul. EXPRESSION BY STRAIN ENGINEERING 26, 2004. (75) Inventors: Thomas M. Ramseier, Poway, CA Publication Classification (US); Hongfan Jin, San Diego, CA (51) Int. Cl. (US); Charles H. Squires, Poway, CA CI2O I/68 (2006.01) (US) GOIN 33/53 (2006.01) CI2N 15/74 (2006.01) Correspondence Address: (52) U.S. Cl. ................................ 435/6: 435/7.1; 435/471 KING & SPALDING LLP 118O PEACHTREE STREET (57) ABSTRACT ATLANTA, GA 30309 (US) This invention is a process for improving the production levels of recombinant proteins or peptides or improving the (73) Assignee: Dow Global Technologies Inc., Midland, level of active recombinant proteins or peptides expressed in MI (US) host cells. The invention is a process of comparing two genetic profiles of a cell that expresses a recombinant (21) Appl. No.: 11/189,375 protein and modifying the cell to change the expression of a gene product that is upregulated in response to the recom (22) Filed: Jul. 26, 2005 binant protein expression. The process can improve protein production or can improve protein quality, for example, by Related U.S. Application Data increasing solubility of a recombinant protein. Patent Application Publication May 25, 2006 Sheet 1 of 15 US 2006/0110747 A1 Figure 1 09 010909070£020\,0 10°0 Patent Application Publication May 25, 2006 Sheet 2 of 15 US 2006/0110747 A1 Figure 2 Ester sers Custer || || || || || HH-I-H 1 H4 s a cisiers TT closers | | | | | | Ya S T RXFO 1961.
    [Show full text]
  • A Bacterial Goldilocks Mechanism
    INSIGHT TWO-COMPONENT SIGNALING PATHWAYS A bacterial Goldilocks mechanism Bacillus subtilis can measure the activity of the enzymes that remodel the cell wall to ensure that the levels of activity are ‘just right’. IRENE M KIM AND HENDRIK SZURMANT detector and a transcription factor that commu- Related research article Dobihal GS, Bru- nicate with one another through the transfer of a net YR, Flores-Kim J, Rudner DZ. 2019. phosphoryl group. Homeostatic control of cell wall hydrolysis An important TCS in the soil bacterium Bacil- by the WalRK two-component signaling lus subtilis and other related bacteria is the pathway in Bacillus subtilis. eLife 8:e52088. WalRK system, which is essential for viability DOI: 10.7554/eLife.52088 (Szurmant, 2012). The system, which is com- prised of the signal-detecting protein WalK and the transcription factor WalR, gets its name from its role in maintaining the cell wall (Dubrac et al., 2007). Together these two com- hen mollusks get bigger, their shells ponents regulate the expression of several auto- grow with them to accommodate lysin genes, including those for the enzymes W the changing shape and size of the LytE and CwlO, which are required for cell elon- organism being housed. Something similar also gation (Salzberg et al., 2013). Now, in eLife, happens in bacteria. The cell wall of most bacte- David Rudner and colleagues at Harvard Medical ria consists of a single macromolecule called School – including Genevieve Dobihal and Yan- peptidoglycan that surrounds the cell and is nick Brunet as joint first authors, along with made up of modified sugars that are crosslinked Josue´ Flores-Kim – report on how the WalRK through peptide side chains.
    [Show full text]
  • The Characterization of a Putative Protease Expressed by Sneathia Amnii
    Virginia Commonwealth University VCU Scholars Compass Theses and Dissertations Graduate School 2015 The Characterization of a Putative Protease Expressed by Sneathia amnii Rana Mehr Virginia Commonwealth University Follow this and additional works at: https://scholarscompass.vcu.edu/etd Part of the Medicine and Health Sciences Commons © The Author Downloaded from https://scholarscompass.vcu.edu/etd/3931 This Thesis is brought to you for free and open access by the Graduate School at VCU Scholars Compass. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of VCU Scholars Compass. For more information, please contact [email protected]. CHARACTERIZATION OF A PUTATIVE PROTEASE EXPRESSED BY SNEATHIA AMNII A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science at Virginia Commonwealth University by RANA MEHR B.S., Virginia Commonwealth University 2011 Director: Kimberly Jefferson, Ph.D. Associate Professor, Department of Microbiology and Immunology Virginia Commonwealth University Richmond, Virginia Virginia Commonwealth University Richmond, Virginia July, 2015 Acknowledgements I would first like to express my deepest gratitude to my mentor Dr. Kimberly Jefferson. Her continuous mentorship, trust, and support in academic, scientific, and personal experiences have empowered me to successfully complete my graduate career both academically and scientifically. She has aided my development as an independent scientist which would have not been possible without guidance. I would also like to thank the members of my graduate advisory committee: Dr. Dennis Ohman and Dr. Darrell Peterson. Their advice and direction have allowed me to better understand my project and their invaluable knowledge has made me a better scientist.
    [Show full text]
  • A Spaetzle-Like Role for Nerve Growth Factor Beta in Vertebrate Immunity to Staphylococcus Aureus
    This is a repository copy of A Spaetzle-like role for nerve growth factor beta in vertebrate immunity to Staphylococcus aureus. White Rose Research Online URL for this paper: http://eprints.whiterose.ac.uk/110810/ Version: Accepted Version Article: Hepburn, L., Prajsnar, T.K., Klapholz, C. et al. (29 more authors) (2014) A Spaetzle-like role for nerve growth factor beta in vertebrate immunity to Staphylococcus aureus. SCIENCE, 346 (6209). pp. 641-646. ISSN 0036-8075 https://doi.org/10.1126/science.1258705 This is the author’s version of the work. It is posted here by permission of the AAAS for personal use, not for redistribution. The definitive version was published in Science on Volume 346, 31 Oct 2014, DOI: 10.1126/science.1258705. Reuse Unless indicated otherwise, fulltext items are protected by copyright with all rights reserved. The copyright exception in section 29 of the Copyright, Designs and Patents Act 1988 allows the making of a single copy solely for the purpose of non-commercial research or private study within the limits of fair dealing. The publisher or other rights-holder may allow further reproduction and re-use of this version - refer to the White Rose Research Online record for this item. Where records identify the publisher as the copyright holder, users can verify any specific terms of use on the publisher’s website. Takedown If you consider content in White Rose Research Online to be in breach of UK law, please notify us by emailing [email protected] including the URL of the record and the reason for the withdrawal request.
    [Show full text]
  • Identification and Characterization of Proteolytic Activities from S. Mutans That Hydrolyzes Dentinal Collagen Matrix
    Identification and Characterization of Proteolytic Activities from S. mutans that Hydrolyzes Dentinal Collagen Matrix Bo Huang, DMD, PhD A thesis submitted in conformity with the requirements for the degree of MSc Faculty of Dentistry University of Toronto © Copyright by Bo Huang (2021) Identification and Characterization of Proteolytic Activities from S. mutans that Hydrolyzes Dentinal Collagen Matrix A thesis submitted in conformity with the requirements for the degree of MSc (2021) Bo Huang, DMD, PhD Faculty of Dentistry University of Toronto Abstract Objective: To measure the proteolytic activity of S. mutans, its discrete fractions, and proteases towards demineralized human dentin. Methods: Demineralized human dentin slabs were incubated with either medium, cultures (overnight or newly inoculated) of S. mutans UA159, or different bacterial fractions (intracellular, supernatant or bacterial membrane). Media from each condition was analyzed for a collagen degradation marker, hydroxyproline. Three potential proteolytic enzymes (SMU_759, SMU_761 and SMU_1438c) from S. mutans UA159 were expressed and their activity toward dentinal collagen was measured based on hydroxyproline analysis. Results: Media only and bacterial membrane had no activity towards dentinal collagen. Overnight culture of S. mutans had the highest degradative activity (p<0.05), followed by supernatant and intracellular component, and newly inoculated culture (p<0.05). SMU_759 had the highest degradative activity towards dentinal collagen, followed by SMU_761 (p<0.05). SMU_1438c showed no collagen degradative activity (p<0.05). Conclusion: S. mutans dentinal collagen degradation could potentially contribute to caries formation. ii Acknowledgments I would like to thank my supervisors, Dr. Yoav Finer and Dr. Dennis Cvitkovitch, for giving me this opportunity to work with them.
    [Show full text]